| Contributors |
|
v | |
| Preface |
|
vii | |
|
Cholesterol transport and synthesis are compromised in the brain in sporadic Alzheimer's disease: from risk factors to therapeutic targets |
|
|
1 | (22) |
|
|
|
Apoptosis and its role in Alzheimer's disease |
|
|
23 | (16) |
|
|
|
|
|
Transgenic models of Alzheimer's disease |
|
|
39 | (14) |
|
|
|
Immunotherapy in Alzheimer's disease |
|
|
53 | (14) |
|
|
|
|
|
Epidemiology of dementia: protective factors |
|
|
67 | (10) |
|
|
|
|
|
|
|
Alzheimer's disease: trial designs to establish disease modification |
|
|
77 | (10) |
|
|
|
|
|
Adopting dementia assessments for international application |
|
|
87 | (10) |
|
|
|
|
|
Biomarkers in Alzheimer's disease |
|
|
97 | (16) |
|
|
|
|
|
Quality of life assessment in dementia research |
|
|
113 | (34) |
|
|
|
|
|
Pharmacoeconomics of dementia: impact of cholinesterase inhibitors |
|
|
147 | (24) |
|
|
|
|
|
Treatment of frontotemporal dementia |
|
|
171 | (12) |
|
|
|
|
|
|
|
Natural history of Alzheimer's disease and other dementing illnesses |
|
|
183 | (16) |
|
|
|
|
|
|
|
Neuropathological changes underlying neuropsychiatric symptoms in Alzheimer's disease |
|
|
199 | |
|
|
|
|
Shopping Cart
